LeadIQ logo
Learn more at LeadIQ.com

Insights

Cutting-Edge Medicines Context Therapeutics is advancing innovative medicines for solid tumors, with a focus on T cell engaging antibodies. Companies in the oncology space seeking novel treatments may be interested in exploring partnership opportunities with Context Therapeutics to expand their product offerings.

Experienced Leadership Team With key appointments to its Board of Directors and leadership team, including prominent figures in the industry, Context Therapeutics demonstrates a commitment to expertise and strategic guidance. Businesses looking to collaborate with established biopharmaceutical leaders could leverage these connections for potential collaborations or shared projects.

Recent Funding Boost Having secured $100M in funding through a private placement, Context Therapeutics has the financial backing to drive its research and development efforts forward. Investors or companies looking to support cutting-edge oncology research may find value in exploring investment or partnership opportunities with Context Therapeutics.

Tech-Savvy Solutions Context Therapeutics utilizes a modern tech stack, incorporating tools like Google Analytics, jQuery, and Webpack. Tech companies or service providers specializing in supporting biotech firms with digital solutions could present offerings that complement or enhance Context Therapeutics' technological infrastructure.

Strategic Partnerships By entering into exclusive worldwide license agreements and collaborations with companies like BioAtla, Context Therapeutics showcases a willingness to engage in strategic partnerships for the development and commercialization of innovative therapies. Biotech firms seeking expansion through partnerships could explore synergistic opportunities with Context Therapeutics.

Similar companies to Context Therapeutics

Context Therapeutics Tech Stack

Context Therapeutics uses 8 technology products and services including Google Analytics, Squarespace, Typekit, and more. Explore Context Therapeutics's tech stack below.

  • Google Analytics
    Analytics
  • Squarespace
    Content Management System
  • Typekit
    Font Scripts
  • Google Font API
    Font Scripts
  • Font Awesome
    Font Scripts
  • Modernizr
    Javascript Libraries
  • jQuery
    Javascript Libraries
  • Webpack
    Miscellaneous

Media & News

Context Therapeutics's Email Address Formats

Context Therapeutics uses at least 1 format(s):
Context Therapeutics Email FormatsExamplePercentage
FLast@contexttherapeutics.comJDoe@contexttherapeutics.com
50%
FLast@contexttherapeutics.comJDoe@contexttherapeutics.com
50%

Frequently Asked Questions

Where is Context Therapeutics's headquarters located?

Minus sign iconPlus sign icon
Context Therapeutics's main headquarters is located at 2001 Market Street Suite 3915, Unit 15 Philadelphia, Pennsylvania 19103 US. The company has employees across 1 continents, including North America.

What is Context Therapeutics's phone number?

Minus sign iconPlus sign icon
You can contact Context Therapeutics's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Context Therapeutics's stock symbol?

Minus sign iconPlus sign icon
Context Therapeutics is a publicly traded company; the company's stock symbol is CNTX.

What is Context Therapeutics's official website and social media links?

Minus sign iconPlus sign icon
Context Therapeutics's official website is contexttherapeutics.com and has social profiles on LinkedIn.

What is Context Therapeutics's SIC code NAICS code?

Minus sign iconPlus sign icon
Context Therapeutics's SIC code is 8049 - Offices and Clinics of Health Practitioners, Not Elsewhere Classified NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Context Therapeutics have currently?

Minus sign iconPlus sign icon
As of September 2024, Context Therapeutics has approximately 16 employees across 1 continents, including North America. Key team members include Chief Financial Officer: J. M.Chief Legal Officer & Corporate Secretary: A. L.Chief Medical Officer: C. D. U.. Explore Context Therapeutics's employee directory with LeadIQ.

What industry does Context Therapeutics belong to?

Minus sign iconPlus sign icon
Context Therapeutics operates in the Biotechnology Research industry.

What technology does Context Therapeutics use?

Minus sign iconPlus sign icon
Context Therapeutics's tech stack includes Google AnalyticsSquarespaceTypekitGoogle Font APIFont AwesomeModernizrjQueryWebpack.

What is Context Therapeutics's email format?

Minus sign iconPlus sign icon
Context Therapeutics's email format typically follows the pattern of . Find more Context Therapeutics email formats with LeadIQ.

How much funding has Context Therapeutics raised to date?

Minus sign iconPlus sign icon
As of September 2024, Context Therapeutics has raised $100M in funding. The last funding round occurred on May 02, 2024 for $100M.

When was Context Therapeutics founded?

Minus sign iconPlus sign icon
Context Therapeutics was founded in 2015.
Context Therapeutics

Context Therapeutics

Biotechnology ResearchPennsylvania, United States11-50 Employees

Context Therapeutics Inc. (Nasdaq: CNTX) is a biopharmaceutical company advancing medicines for solid tumors. Context is developing CTIM-76, a selective Claudin 6 (CLDN6) x CD3 bispecific antibody for CLDN6-positive tumors, currently in preclinical development. Context is headquartered in Philadelphia. For more information, visit www.contexttherapeutics.com.

Section iconCompany Overview

Headquarters
2001 Market Street Suite 3915, Unit 15 Philadelphia, Pennsylvania 19103 US
Phone number
SIC Code
8049 - Offices and Clinics of Health Practitioners, Not Elsewhere Classified
Stock Symbol
CNTX
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2015
Employees
11-50

Section iconFunding & Financials

  • $100M

    Context Therapeutics has raised a total of $100M of funding over 3 rounds. Their latest funding round was raised on May 02, 2024 in the amount of $100M.

Section iconFunding & Financials

  • $100M

    Context Therapeutics has raised a total of $100M of funding over 3 rounds. Their latest funding round was raised on May 02, 2024 in the amount of $100M.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.